SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing heightened volatility due to recent downgrades from Bank of America and Goldman Sachs, which many in the community are interpreting as manipulative tactics by competing institutions. Despite the short-term price pressure, a significant portion of investors remain highly bullish, viewing the dip as a prime buying opportunity ahead of upcoming earnings and potential S&P inclusion, confident in the company's long-term growth trajectory.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending amidst its CES 2026 presence, where CEO Lisa Su unveiled new AI processors and a robust product roadmap, including the MI500 series aimed at significant AI performance gains. Despite an initial sell-off and community chatter about market manipulation, many are actively 'buying the dip,' bullish on AMD's aggressive product roadmap and long-term potential in the burgeoning AI and data center markets, challenging rivals like Nvidia.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant market momentum, primarily fueled by reports of persistent memory shortages and increasing demand for its storage solutions within the rapidly expanding AI infrastructure. This has created a highly polarized community discussion, with some investors celebrating its 'unstoppable' rise as a 'generational shift,' while others caution about an overextended 'bubble' and potential for sharp pullbacks.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following its CES announcements, showcasing the Vera Rubin AI supercomputer and Alpamayo platform for autonomous vehicles. While enthusiasts celebrate these innovations as transformative for AI and robotics, many traders express frustration over the stock's struggle to sustain gains amid perceived market manipulation. The broader context reinforces NVIDIA's expanding role as a foundational technology provider in the evolving AI economy.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending after multiple analyst upgrades, with several firms designating it a "top pick" for 2026 and initiating or raising outlooks for a multi-year recovery. The community is actively discussing the stock's potential as a defensive play and a "safe haven" for capital, anticipating upward movement driven by strong fundamentals and upcoming financial reports.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Alumis is surging after announcing positive Phase 3 results for its oral TYK2 inhibitor, envudeucitinib, in moderate-to-severe plaque psoriasis, showcasing strong skin clearance and a favorable safety profile that outperformed existing treatments. The community is buzzing with optimism about the drug's "best-in-class" potential and significant market opportunity, while others remain cautious, anticipating a potential secondary offering following the initial spike.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY Coin is currently trending with heightened trading volume, fueled by strong community anticipation for significant 2026 developments across decentralized AI, DePIN, and secure data monetization via its Layer-2 network. Supporters emphasize its foundational utility, regulatory compliance in Japan, and ex-Sony leadership as key strengths, though some investors remain cautious due to historical price volatility.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is trending following an agreement for Project TETRA, a DOE initiative to construct and operate a pilot reactor, which the community sees as a significant federal fast-track contract. Investors are actively comparing it to OKLO, highlighting its molten salt reactor technology and government backing as key differentiators for powering the growing demands of the AI revolution and industrial heat. Many view current levels as a long-term accumulation opportunity within the advanced nuclear sector.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

PMGC Holdings Inc.

PMGC Holdings Inc. (ELAB) is experiencing extreme volatility following a recent reverse stock split that created an exceptionally low float, driving community speculation about a potential short squeeze due to high cost-to-borrow. This comes alongside news of a strategic acquisition in the micro modular reactor sector and advancements in an AI-driven drug discovery program, though many investors express strong skepticism, citing the company's history of dilution and repeated reverse splits.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is generating significant buzz following its recent substantial debt reduction and the strategic acquisition of Ask Sage, firmly positioning the company in secure generative AI for defense and government sectors. The community is actively discussing the imminent potential for major government contract wins, often drawing comparisons to early Palantir, despite some persistent chatter about potential share dilution. Many investors foresee a breakout into double-digit prices, driven by its strengthened financial position and perceived critical role in national security applications.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cannabis ETF (CNBS) Hits New 52-Week High

CNBS Cannabis ETF climbs to a 52-week high, fueled by rescheduling optimism and potential further gains.

<ul class="summary-bullets"><li>Tilray’s shares, as well as shares of other Cannabis producers, have been surging over the past few days.</li><li>This comes amid reports that President Trump is set to reclassify marijuana, which would result in cannabis companies falling under different tax regulations.</li><li>While awaiting the executive order, retail users on Stocktwits expressed optimism, noting that the TLRY stock could rally even further.</li></ul>Shares of Tilray Brands Inc. (TLRY) have soared nearly 72% over the past five trading sessions as investors await President Donald Trump’s executive order on marijuana reclassification.The New York City-headquartered pharmaceutical company produces and distributes cannabis for medicinal and adult use.Tilray’s shares, as well as shares of other Cannabis producers, have been surging over the past few days amid reports that President Trump is set to reclassify marijuana, which would result in cannabis companies falling under different tax regulations.<a href="https://stocktwits.com/symbol/TLRY">Tilray shares</a> were up nearly 5% in Wednesday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘extremely bullish’ territory, with the stock being the top trending ticker on the platform at the time of writing.<h2 class="st-heading-2">Retail’s Excited</h2>While awaiting the executive order, retail users on Stocktwits expressed optimism, noting that the TLRY stock could rally even further. One user expects Tilray’s shares to surge past $20 on Wednesday with ease.<stembedurl>https://stocktwits.com/LifeChangingProfits/message/639396013</stembedurl>Another user compared the reclassification of marijuana to a biotech company receiving fast-track approval from the U.S. Food and Drug Administration (FDA) for ten Phase 3 trials simultaneously.<stembedurl>https://stocktwits.com/Hoschton30548/message/639132205</stembedurl>One user expects the TLRY stock to surge past $50 by the end of the year.<stembedurl>https://stocktwits.com/Family2328/message/639372092</stembedurl><h2 class="st-heading-2">Other Cannabis Stocks Surge</h2>Apart from Tilray, expectations of marijuana reclassification have sent other cannabis stocks soaring, too.Canopy Growth Corp. (CGC), an Ontario-based company, saw its shares climb nearly 62% over the past five trading sessions. Aurora Cannabis Inc. (ACB) shares have climbed over 20%, while the Amplify Seymour Cannabis ETF (CNBS) has soared nearly 71% during this period.<h2 class="st-heading-2">Marijuana Reclassification</h2>According to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?id=128472615">report</a> by ABC News citing people familiar with the matter, President Trump is set to sign an executive order on Wednesday that would reclassify marijuana as a Schedule III drug.Under the current Drug Enforcement Administration guidelines, marijuana is listed as a Schedule I drug. The DEA defines Schedule III drugs as having “a moderate to low potential for physical and psychological dependence.”<a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> is up 5% year-to-date and 16% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ford-terminates-6-5-billion-battery-deal-lg-energy-after-retreating-from-evs/cLeOWmAREpD">Ford Terminates $6.5 Billion LG Energy Deal After Retreating From EVs — And Retail Is Split</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

TLRY Stock Gained Over 70% In 5 Days, Retail Optimism Spikes Ahead Of Trump's Marijuana Order

The New York City-headquartered pharmaceutical company produces and distributes cannabis for medicinal and adult use.

Equity

6 Top-Performing ETF Areas of Last Week 

Cannabis, metals, space and health care led ETF gains last week. WEED, CNBS, SIL, UFO, GDXJ, PLTM and OZEM outperformed despite tech weakness.

5 Best-Performing Leveraged ETFs of Last Week

Cannabis, space, nat gas & auto led last week's leveraged ETF winners. MSOX, RKLX, KOLD, VOYX and CVNX posted outsized gains despite tech weakness.

Cannabis ETFs Soar Double-Digits on Friday: Here's Why

Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.

The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO

Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects 

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism. 

Top-Performing ETF Areas of August That Are Up At Least 20% 

ETFs tied to Cannabis, Asia, China, materials and bitcoin miners led August's gains in Wall Street. ETFs like WEED, KSTR, CNXT, GBUG and WGMI won in August.

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.


Tilray Brands, Inc. faces a regulatory reckoning: regain Nasdaq’s minimum bid price requirements soon or possibly get delisted from the exchange.&nbsp;The retail trading community on Stocktwits believes the cannabis and beer company will soon overcome this hurdle.Leamington, Canada-based Tilray received a non-compliance notice from Nasdaq on Tuesday after its stock failed to maintain the exchange’s $1 minimum closing bid price requirement for 30 consecutive business days.Shares of Tilray have lost more than half their value this year, as cannabis-linked stocks continue to struggle amid stalled federal legalization efforts.The company has 180 calendar days to meet Nasdaq's minimum bid price rule. Its stock must close at or above $1.00 per share for at least 10 consecutive business days before Sept. 21.If the company fails, it may transfer to the Nasdaq Capital Market for another 180-day extension — provided it meets other listing requirements and notifies Nasdaq of its plan to fix the issue, possibly through a reverse stock split.&nbsp;If Nasdaq still determines the company cannot regain compliance, its stock will face delisting.On Stocktwits, sentiment for Tilray ended on a slightly higher ‘bullish’ level on Wednesday amid a 45% jump in message volume.<figure class="image"><img style="aspect-ratio:1318/302;" src="https://news.stocktwits-cdn.com/TLRY_sentiment_and_message_volume_as_of_Macrh_26_png_785b929906.webp" alt="TLRY sentiment and message volume as of Macrh 26.png" width="1318" height="302"><figcaption>TLRY sentiment and message volume as of Macrh 26. | source: Stocktwits</figcaption></figure>One user expressed hopes of Nasdaq being lenient with its process and said there were “zero” delisting fears because, with the extension, Tilray has until April 2026 to regain compliance.<stembedurl>https://stocktwits.com/Finance88/message/609341203</stembedurl>Another user said the company is “vertically scaled to be dominant from flower to drinks to pharma,” pointing to its products being available on the multinational supermarket chain Whole Foods, which is owned by Amazon.com.<stembedurl>https://stocktwits.com/Heb1972/message/609362664</stembedurl>Several retail investors on Stocktwits hope Tilray does not resort to a reverse stock split.<stembedurl>https://stocktwits.com/Rs1015/message/609258289</stembedurl>In January, Tilray’s stock was dealt a blow after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tlry-stock-slides-after-q2-2025-results/chGWAd2RZD">reported</a> disappointing quarterly results and projected a $20 million revenue blow for 2025 from cutting back on certain alcohol beverage brands.Meanwhile, the company said Wednesday that the Massachusetts Superior Court dismissed a lawsuit filed by a shareholder against the company and its subsidiary Hexo.The plaintiff claimed Tilray failed to inform shareholders about Hexo’s corporate actions in late 2022 and its 2023 acquisition, allegedly causing financial losses. He sought nearly $8 million in damages.&nbsp;According to Koyfin data, short interest on Tilray has shot up from 12.7% at the start of the year to 17.3% as of the last week.The stock trades at a significant 180% discount to Wall Street’s average price target of $1.83. Out of 13 analysts covering it, nine rate it ‘hold’ and four ‘buy.’For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of a Canadian pharmaceutical and cannabis company, Tilray, is seen on a smartphone and a PC screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Tilray Retail Bulls See Nasdaq Compliance On The Horizon, Shareholder Lawsuit Victory Adds Cheer

The company has 180 calendar days to meet Nasdaq's minimum bid price rule. Its stock must close at or above $1.00 per share for at least 10 consecutive business days before Sept. 21.

Amplify ETF Trust - Amplify Seymour Cannabis ETF

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

CNBS
Amplify Seymour Cannabis ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest CNBS News

CNBSAmplify Seymour Cannabis ETF